Unknown

Dataset Information

0

An experimental test of the nicotinic hypothesis of COVID-19.


ABSTRACT: The pathophysiological mechanisms underlying the constellation of symptoms that characterize COVID-19 are only incompletely understood. In an effort to fill these gaps, a "nicotinic hypothesis," which posits that nicotinic acetylcholine receptors (AChRs) act as additional severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptors, has recently been put forth. A key feature of the proposal (with potential clinical ramifications) is the suggested competition between the virus' spike protein and small-molecule cholinergic ligands for the receptor's orthosteric binding sites. This notion is reminiscent of the well-established role of the muscle AChR during rabies virus infection. To address this hypothesis directly, we performed equilibrium-type ligand-binding competition assays using the homomeric human α7-AChR (expressed on intact cells) as the receptor, and radio-labeled α-bungarotoxin (α-BgTx) as the orthosteric-site competing ligand. We tested different SARS-CoV-2 spike protein peptides, the S1 domain, and the entire S1-S2 ectodomain, and found that none of them appreciably outcompete [125I]-α-BgTx in a specific manner. Furthermore, patch-clamp recordings showed no clear effect of the S1 domain on α7-AChR-mediated currents. We conclude that the binding of the SARS-CoV-2 spike protein to the human α7-AChR's orthosteric sites-and thus, its competition with ACh, choline, or nicotine-is unlikely to be a relevant aspect of this complex disease.

SUBMITTER: Godellas NE 

PROVIDER: S-EPMC9636949 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

An experimental test of the nicotinic hypothesis of COVID-19.

Godellas Nicole E NE   Cymes Gisela D GD   Grosman Claudio C  

Proceedings of the National Academy of Sciences of the United States of America 20221024 44


The pathophysiological mechanisms underlying the constellation of symptoms that characterize COVID-19 are only incompletely understood. In an effort to fill these gaps, a "nicotinic hypothesis," which posits that nicotinic acetylcholine receptors (AChRs) act as additional severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptors, has recently been put forth. A key feature of the proposal (with potential clinical ramifications) is the suggested competition between the virus' spike pr  ...[more]

Similar Datasets

| PRJEB38185 | ENA
| S-EPMC7984094 | biostudies-literature
| S-EPMC4611659 | biostudies-literature
| S-EPMC2677602 | biostudies-literature
| S-EPMC7248130 | biostudies-literature
| S-BSST563 | biostudies-other
| S-EPMC10928216 | biostudies-literature
| S-EPMC7276636 | biostudies-literature
| S-EPMC7528823 | biostudies-literature
| S-EPMC5696418 | biostudies-literature